Sino Biopharmaceutical reported CNY2.49B in Cost of Sales for its fiscal semester ending in December of 2024.


Cost Of Sales Change Date
Alaunos Therapeutics 0 18K Sep/2024
Avita Medical AUD 2.28M 170K Dec/2024
Cspc Pharmaceutical CNY 2.31B 299.94M Mar/2025
Ionis Pharmaceuticals USD 4.15M 3.15M Jun/2025
IQVIA Holdings USD 2.97B 439M Jun/2025
Jiangsu Hengrui CNY 1.05B 22.36M Jun/2025
Moderna USD 119M 29M Jun/2025
Organon & Co USD 720M 48M Jun/2025
Revvity USD 327.73M 38.51M Jun/2025
Sino Biopharmaceutical CNY 2.49B 353.34M Dec/2024
Viatris USD 2.25B 229.7M Jun/2025
Xeris Pharmaceuticals USD 11.9M 2.42M Jun/2025